Skip to main content

Advertisement

Log in

Increased concentration of hypoxanthine in human central cerebrospinal fluid after subarachnoid haemorrhage

  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Summary

The adenine nucleotide metabolites hypoxanthine, xanthine and uric acid were determined by high performance liquid chromatography in cerebrospinal fluid (CSF) from 25 patients with subarachnoid haemorrhage (SAH) and from 26 control subjects. In addition, the haemoglobin and protein levels in the CSF of the patients were determined.

In 13 subjects, from which lumbar CSF was collected three, six and nine days after SAH, there was a gradual increase in 8 patients for hypoxanthine and in 3 of the 13 patients for xanthine and uric acid. The mean concentrations were not significantly higher than the controls. In 12 SAH patients, consecutive CSF fractions of 10 ml were collected peroperatively during surgical clipping of aneurysms. The hypoxanthine concentrations increased continously from lumbar to central CSF samples. Hypoxanthine levels were 6.5±1.0 μM in lumbar CSF compared to 11.8±2.3 μM in central CSF (p<0.001), while xanthine, uric acid, haemoglobin and protein levels were equally distributed. Furthermore, the SAH patients showed about 3 times higher concentrations of central CSF hypoxanthine (p<0.01) and xanthine (p<0.05) while that for uric acid was similar compared to all control subjects. Also, an in vitro study showed that the increased concentrations of the adenine nucleotide metabolites could not be caused by degradation of blood components in the subarachnoid space.

It is presumed that the increased central CSF concentrations of hypoxanthine that were demonstrated in patients after SAH could be a sensitive marker for brain tissue ischaemia. However, since there was no correlation between the hypoxanthine levels, clinical condition or cerebral vascular diameter, other factors have to be excluded before ischaemia alone could explain the elevated central hypoxanthine levels in patients without major clinical dysfunction after SAH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Al-Khalidi, U. A. S., Chaglassian, T. H., The species distribution of xanthine oxidase. Biochem. J.97 (1965), 318–320.

    Google Scholar 

  2. Bergvall, U., Steiner, L., Forster, D. M. C., Early pattern of cerebral circulatory disturbances following subarachnoid hemorrhage. Neuroradiol.5 (1973), 24–32.

    Google Scholar 

  3. Briem, H., Hultman, E., Concentration of hypoxanthine in cerebrospinal fluid compared with concentrations of lactate and total amino acids. Thesis. Stockholm 1982.

  4. Ekbom, K., Greitz, T., Carotid angiography in cluster headache. Acta Radiol. Diagn. (1969), 1–10.

  5. Fein, J., Brain energetics and circulatory controls after subarachnoid hemorrhage. J. Neurosurg. (1976), 498–507.

  6. Fujishima, M., Sugi, T., Choki, T., Yamaguchi, T., Omae, T., Cerebrospinal fluid and arterial lactate, pyruate and acid-base balance in patients with intracranial hemorrhages. Stroke (1975), 707–713.

  7. Gabrielson, G., Greitz, T., Normal size of the internal carotid, middle cerebral and anterior cerebral arteries. Acta Radiol. Diagn.10 (1970), 1–10.

    Google Scholar 

  8. Grubb, R. L., Raichle, M. E., Eichling, J. O., Gado, M. H., Effects of subarachnoid hemorrhage on cerebral blood volume, blood flow and oxygen utilisation in humans. J. Neurosurg.46 (1977), 446–453.

    PubMed  Google Scholar 

  9. Grubb, R. L., Cerebral hemodynamics and metabolism in subarachnoid hemorrhage and vasospasm. In: Cerebral Arterial Spasm (Wilkins, R., ed.), pp. 341–349. Baltimore 1980.

  10. Hunt, W. E., Hess, R. M., Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J. Neurosurg. (1976), 14–20.

  11. Hällgren, R., Niklasson, F., Terent, Åkerblom, Å., Widerlöw, E., Oxypurines in cerebrospinal fluid as indices of disturbed brain metabolism. A clinical study of ischemic brain diseases. Stroke14, No. 3 (1983), 382–388.

    PubMed  Google Scholar 

  12. Jenneth, B., Bond, M., Assessment of outcome after severe brain damage. Lancet (1975), 480.

  13. Kleihues, P., Kobayashy, K., Hossman, K., Purine nucleotide metabolism in the cat brain after one hour of complete ischemia. J. Neurochem.23 (1974), 417–425.

    PubMed  Google Scholar 

  14. Kreutzberg, G. W., Barron, K. D., Schubert, P., Cytochemical localisation of 5′-nucleotidase in glial plasma membranes. Brain Res.158 (1978), 247–257.

    PubMed  Google Scholar 

  15. Kågström, E., Greitz, T., Hansson, J., Galera, R., Changes in cerebral blood flow after subarachnoid hemorrhage. Preceedings of the III international Congress of Neurological Surgery. Copenhagen 23–28 August 1965. International Congress series No. 110, p. 629. Amsterdam: Excerpta Medica Foundation.

    Google Scholar 

  16. Lagerkrantzer, M., Sollevi, A., Ihrestedt, L., Lindquist, C., Gordon, E., Cerebral blood flow and metabolism during adenosine induced hypotension in patients undergoing aneurysm surgery. In manuscript.

  17. Lowry, O., Rosenbrough, N., Farr, A., Randall, J., Protein measurements with the folin phenol reagent. J. Biol. Chem.193 (1951), 265–275.

    PubMed  Google Scholar 

  18. Manzke, H., Staemmler, W., Dörner, K., Increased nucleotide metabolism after cerebral convulsion. Neuropediatrics12 (1981), 119–131.

    PubMed  Google Scholar 

  19. Manzke, H., Staemmler, W., Oxipurine concentration in the CSF from children with different diseases of the nervous system. Neuropediatrics12 (1981), 209–214.

    PubMed  Google Scholar 

  20. McIlwain, H., Regulatory significance of the release and action of adenine derivatives in cerebral system. Biochem. Soc. Symp.36 (1972), 69–85.

    PubMed  Google Scholar 

  21. McIlwain, H., Transport of adenine derivatives in tissue of the brain. Adv. Exp. Med. Biol.69 (1976), 253–264.

    PubMed  Google Scholar 

  22. Meberg, A., Saugstad, O. D., Hypoxanthine in cerebrospinal fluid in children. Scand. J. clin. Lab. Invest.38 (1978), 437–440.

    PubMed  Google Scholar 

  23. Millikan, C. H., Cerebral vasospasm and ruptured intracranial aneurysm. Arch. Neurol.32 (1975), 433–449.

    PubMed  Google Scholar 

  24. Nordström, C.-H., Rehnchrona, S., Siesjö, B., Effect of phenobarbital in cerebral ischemia. Part II: Restitution of cerebral energy state as well as of glycolytic metabolites, citric acid cycle intermediates and associated amino acids after pronounced incomplete ischemia. Stroke9 (1978), 335–343.

    PubMed  Google Scholar 

  25. Ohisalo, J. J., Murros, K., Fredholm, B. B., Hare, T. A., Concentrations of gammaaminobutyric acid and adenosine in the CSF in progressive myoclonus epilepsy without lafora's bodies. Arch. Neurol.40 (1983), 623–625.

    PubMed  Google Scholar 

  26. Phillis, J. W., Kstopoulos, G. K., Adenosine as a putative transmitter in the cerebral cortex; studies with potentiators and antagonists Life Sci.17 (1975), 1085–1094.

    PubMed  Google Scholar 

  27. Schweinberg, P. D., Loo, T. L., Simultaneous analysis of ATP, ADP, AMP and other purines in humn erythrocytes by HPLC. J. Chromatography181 (1980), 103–107.

    Google Scholar 

  28. Siesjö, B., Brain Energy Metabolism. Wiley and Sons Ltd. 1978.

  29. Symond, L., Vasospasm in Neurosurgery. In: Vascular Diseases. Proceedings of the 7th Princeton Conference on Cerebrovascular Diseases (Moosy, J., Janeway, R., eds.), pp. 232–240. New York: Grune and Stratton. 1971.

    Google Scholar 

  30. Symond, L., Bell, B. A., Kendall, B. E., The relationship between vasospasm and cerebral ischemia and infarction. In: Cerebral Arterial Spasm (Wilkins, R., ed.), pp. 372–377. Baltimore: Williams and Wilkins. 1980.

    Google Scholar 

  31. Voldby, B., Enevoldsen, E. M., Intracranial pressure changes following aneurysm rupture. Art 2: Associated cerebrospinal fluid lactacidosis. J. Neurosurg.56 (1982), 197–204.

    PubMed  Google Scholar 

  32. Wahlgren, N. G., Bergström, K., Determination of haem derivatives in the cerebrospinal fluid—a semiquantitative method. J. Neurol. Neurosurg. Psychiat.46 (1983), 553–568.

    Google Scholar 

  33. Welsh, F. A., Okonnor, M. J., Marzy, V. R., Pattacco, A. J., Johns, R., Factors limiting a regeneration of ATP following temporary ischemia in cat brain. Stroke13 (1982), 234–242.

    PubMed  Google Scholar 

  34. Winer, B. J., Statistical principles in experimental design. Second edition. New York: McGraw Hill. 1971.

    Google Scholar 

  35. Winn, H. R., Rubio, R., Berne, R., Metabolic fate of adenosine in cerebrospinal fluid. In: Neurobiology of Cerebrospinal Fluid (Wood, J. E., ed.), pp. 591–601. Plenum Press. 1983.

  36. Winn, H. R., Rubio, R., Berne, R., Brain adenosine concentration during hypoxia in rat. Amer. J. Physiol.241 (1981), H 235-H 242.

    Google Scholar 

  37. Zetterström, T., Verne, L., Ungerstedt, U., Tossman, U., Johnson, V., Fredholm, B. B., Purine levels in the intact brain. Studies with an implanted perfused hollow fibre. Neuroscience Letters29 (1981), 111–115.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This study was supported by grants from Karolinska Institutet, the Swedish National Society against Heart and Chest disease, The Swedish Society of Medical Sciences, Wibergs Foundation, Boehringer Ingelheim and the Swedish Medical Research Council (proj. no. 7485).

Rights and permissions

Reprints and permissions

About this article

Cite this article

von Holst, H., Sollevi, A. Increased concentration of hypoxanthine in human central cerebrospinal fluid after subarachnoid haemorrhage. Acta neurochir 77, 52–59 (1985). https://doi.org/10.1007/BF01402306

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01402306

Keywords

Navigation